C. Wagner

发表

Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stress.

S. Wagner, B. Garg, G. Pathria, 2016, Mutagenesis.

NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo

K. Mertz, S. Wagner, G. Stingl, 2013, PloS one.

Hsp90 Inhibition Affects Cell Metabolism by Disrupting Mitochondrial Protein Insertion

P. Oefner, E. Geissler, K. Dettmer, 2014 .

Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.

B. Ghanim, C. Pirker, W. Berger, 2014, American journal of respiratory and critical care medicine.

Comprehensive comparative and semiquantitative proteome of a very low number of native and matched epstein-barr-virus-transformed B lymphocytes infiltrating human melanoma.

K. Bennett, S. Wagner, J. Colinge, 2014, Journal of proteome research.

B cells sustain inflammation and improve survival in human melanoma

K. Mertz, S. Wagner, M. Herlyn, 2018, bioRxiv.

Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis12

C. Hellerbrand, E. Geissler, H. Schlitt, 2018, Neoplasia.

Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells

U. Jaehde, G. V. Kalayda, J. Reedijk, 2008, BMC Cancer.

CpG motifs are efficient adjuvants for DNA cancer vaccines.

S. Wagner, G. Stingl, Anja Zemann, 2004, The Journal of investigative dermatology.

Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy

S. Wagner, C. Wagner, M. Goos, 1997, Cancer Immunology, Immunotherapy.

Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas.

H. Soyer, S. Wagner, H. Ockenfels, 1996, The Journal of investigative dermatology.

Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.

H. Höfler, S. Wagner, M. Schmitt, 1995, The American journal of pathology.

Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivo.

S. Wagner, G. Stingl, C. Wagner, 2000, The Journal of investigative dermatology.

A Peptide to Reduce Pulmonary Edema in a Rat Model of Lung Transplantation

S. Wagner, M. Schultz, D. Wiedemann, 2015, PloS one.

Direct Targeting Options for STAT3 and STAT5 in Cancer

R. Moriggl, G. Keserű, M. Herling, 2019, Cancers.

Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.

U. Jaehde, C. Wagner, G. Kalayda, 2012, Journal of inorganic biochemistry.

Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney

H. Höfler, S. Wagner, M. Schmitt, 2005, Histochemistry and Cell Biology.

Single-cell RNA sequencing analyses of primary cutaneous B-cell disorders reveal distinct molecular patterns consistent with clinical behavior

S. Wagner, J. Griss, M. Farlik, 2022, bioRxiv.

Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination.

T. Mak, X. Nguyen, M. A. Kamal, 2011, Blood.

Loss of Ing3 Expression Results in Growth Retardation and Embryonic Death

T. Rülicke, K. Riabowol, S. Handschuh, 2019, Cancers.

Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells

G. Superti-Furga, S. Wagner, B. Garg, 2016, Cell Death and Disease.

Blockage of 2-Deoxy-d-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy

Markus Guba, Erika Frank, Christiane J Bruns, 2004, Clinical Cancer Research.

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma

T. Golub, Jean-Philippe Brunet, S. Ramaswamy, 2012, Journal of the National Cancer Institute.

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma

Johannes Griss, Christoph Bock, Martin Simon, 2019, Nature Communications.

Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.

K. Mertz, S. Wagner, I. Wolf, 2016, Human pathology.

Loss of Lymphotoxin Alpha-Expressing Memory B Cells Correlates with Metastasis of Human Primary Melanoma

K. Mertz, S. Wagner, J. Griss, 2021, Diagnostics.

A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration

K. Mertz, S. Wagner, J. Griss, 2021, Frontiers in Immunology.

Spatiotemporal Analysis of B Cell- and Antibody Secreting Cell-Subsets in Human Melanoma Reveals Metastasis-, Tumor Stage-, and Age-Associated Dynamics

K. Mertz, S. Wagner, J. Griss, 2021, Frontiers in Cell and Developmental Biology.

MTSS1 is a metastasis driver in a subset of human melanomas

L. Chin, A. Sboner, K. Mertz, 2014, Nature Communications.

Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA.

H. Höfler, S. Wagner, M. Atkinson, 1995, Laboratory investigation; a journal of technical methods and pathology.

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance

Johannes Griss, Zhi Wei, Jie Zhang, 2017, Nature Communications.

Growth factor-induced epithelioid-sarcomatoid transition in malignant pleural mesothelioma cells?

C. Wagner, 2015 .

Arabidopsis thaliana DM2h (R8) within the Landsberg RPP1-like Resistance Locus Underlies Three Different Cases of EDS1-Conditioned Autoimmunity

G. V. James, J. Parker, Rubén Alcázar, 2016, PLoS genetics.

The Elongated First Fibronectin Type III Domain of Collagen XIV Is an Inducer of Quiescence and Differentiation in Fibroblasts and Preadipocytes*

Hadi Al-Hasani, D. Schuppan, R. Somasundaram, 2005, Journal of Biological Chemistry.

Polo-like kinase 1 is a potential therapeutic target in human melanoma.

S. Ramaswamy, S. Wagner, G. Stingl, 2011, The Journal of investigative dermatology.

FGF2 and EGF induce epithelial–mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal

C. Pirker, T. Mohr, W. Berger, 2018, Carcinogenesis.

Farmland versus forest: comparing changes in Odonata species composition in western and eastern Sweden

G. Sahlén, C. Wagner, Kamilla Koch, 2014 .

Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer.

O. Stoeltzing, E. Geissler, H. Schlitt, 2012, Anticancer research.

Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model

E. Geissler, H. Schlitt, C. Wagner, 2015, BMC Cancer.

Cancer-associated cells release citrate to support tumour metastatic progression

S. Haferkamp, K. Drexler, Christian Schmidl, 2021, Life Science Alliance.

Inhibition of neurosphere proliferation by IFNγ but not IFNβ is coupled to neuronal differentiation

A. Turnley, E. Croze, C. Wagner, 2009, Journal of Neuroimmunology.

Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.

S. Wagner, S. Koller, J. Smolle, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeting CD20 in melanoma patients at high risk of disease recurrence.

S. Wagner, M. Herlyn, G. Karanikas, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Induction of targeted cell migration by cutaneous administration of a DNA vector encoding a biologically active chemokine CCL21.

S. Wagner, E. Kriehuber, G. Stingl, 2010, The Journal of investigative dermatology.

Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.

S. Wagner, G. Pathria, C. Wagner, 2012, The Journal of investigative dermatology.

Combining filter-aided sample preparation and pseudoshotgun technology to profile the proteome of a low number of early passage human melanoma cells.

K. Bennett, S. Wagner, A. Müller, 2013, Journal of proteome research.

Dual c‐Jun N‐terminal kinase–cyclin D1 and extracellular signal‐related kinase–c‐Jun disjunction in human melanoma

S. Wagner, B. Garg, G. Pathria, 2016, The British journal of dermatology.

Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression.

J. Becker, S. Wagner, C. Wagner, 1998, Laboratory investigation; a journal of technical methods and pathology.

Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma.

H. Höfler, S. Wagner, H. Ockenfels, 1995, The Journal of investigative dermatology.

Inhibition of CRM1-Mediated Nucleocytoplasmic Transport: A New Approach to Trigger Human Melanoma Cell Apoptosis by Perturbing Multiple Cellular Pathways

S. Wagner, G. Pathria, C. Wagner, 2012 .

CD44 variant isoform v10 is expressed on tumor‐infiltrating lymphocytes and mediates hyaluronan‐independent heterotypic cell–cell adhesion to melanoma cells

S. Wagner, C. Wagner, M. Goos, 2003, Experimental dermatology.

Transcription alterations of members of the ubiquitin–proteasome network in prostate carcinoma

T. Schlomm, H. Sültmann, O. Hellwinkel, 2011, Prostate Cancer and Prostatic Diseases.

The antiangiogenic action of cisplatin on endothelial cells is mediated through the release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells

R. Ramer, B. Hinz, C. Wagner, 2018, Oncotarget.

Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.

L. Ellis, O. Stoeltzing, Wenbiao Liu, 2007, Cancer letters.

A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF

G. Superti-Furga, K. Bennett, S. Wagner, 2014, Oncogene.

RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.

S. Wagner, B. Garg, G. Pathria, 2015, The Journal of investigative dermatology.

PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients

C. Krall, C. Wagner, T. Fuereder, 2019, Front. Oncol..

A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue

T. Schlomm, H. Sültmann, T. Steuber, 2013, International journal of molecular sciences.

Hyaluronan-independent adhesion of CD44H+ and CD44v10+ lymphocytes to dermal microvascular endothelial cells and keratinocytes.

S. Wagner, C. Wagner, M. Goos, 2001, The Journal of investigative dermatology.

Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.

U. Reinhold, S. Wagner, M. Zöller, 1998, The Journal of investigative dermatology.

Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.

C. Hellerbrand, E. Geissler, H. Schlitt, 2015, Anticancer research.

MTSS1 is a metastasis driver in a subset of human melanomas

L. Chin, A. Sboner, K. Mertz, 2014, Nature Communications.